Levothyroxine, commercially known as Synthroid among other names, is commonly used to treat an underactive thyroid.

Commonly prescribed thyroid drug levothyroxine was linked with bone mass and bone density loss in a cohort of older adults in ...

Fact checked by Nick BlackmerLevothyroxine, a common medication for hypothyroidism sold as Synthroid, is linked to bone loss ...

A widely used pill for treating an underactive thyroid may be associated with bone loss, according to a study being presented ...

A drug called levothyroxine, the second-most-commonly prescribed medication among older U.S. adults, has been linked to a higher risk of bone loss in a new study. Levothyroxine is prescribed to ...

Improve bone strength, prevent osteoporosis, and boost bone density with expert-backed exercises and nutrition strategies.

A popular thyroid medication taken by 23 million Americans may be associated with bone loss, a startling new study finds. Levothyroxine — marketed under brand names such as Synthroid — is the ...

according to the latest findings to show that the rapid rebound of bone loss after denosumab discontinuation is not easily prevented with other therapies — even bisphosphonates. “When ...

New research links the thyroid medicine to potential bone loss. Dr. Yadal Safai says the study was “quite small” and that “much more research needs to be done” before doctors change their ...

Bone health experts are urging Filipinos, especially those aged 50 and above, and their families, to prioritize osteoporosis ...

Levothyroxine, the second most commonly prescribed medication among older adults in the U.S., may be associated with bone loss, according to a study being presented next week at the annual meeting ...